Agencies, 25 August: Tuesday te Drug firm FDC Ltd para COVID-19 drug Favipiravir laga tuita variants toh b rand naam PiFLU aro Favenza te suru korise.
FDC para statement te koise, “Poila Drug Controller General of India (DCGI) para Favipiravir toh jolabole nemide mana thakise kelay koile mild to moderate symptoms laga COVID-19 patients logode joldi clinical recovery dekha nemide”.
FDC spokesperson Mayank Tikkha koise, bemari te joldi jana aro treatment kora para patients laga halat beya hoi thaka te phal hobole motob pabo. Spokesperson Mayank para be desh te Favenza aro PiFLU toh thakibo nemide tai khan government aro healthcare fraternity logode kaam kori ase koise.
Company koise, tuita saman be desh te available ase. Tuita variants laga daam be per tablet te Rs 55 ase koise.
India te Favipiravir laga tuita variants suru korise
Add Comment